Evidence for altered trisynaptic circuitry in schizophrenic hippocampus

Biological Psychiatry

Volumn 46, Issue 5, 1999, Pages 589-599

  Benes, Francine M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Disinhibitory; GABA; Glutamate; Inhibitory; Uncoupling

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MESSENGER RNA;

CONFERENCE PAPER; HIPPOCAMPUS; HUMAN; INTERNEURON; PRIORITY JOURNAL; SCHIZOPHRENIA; STRESS;

ANTIPSYCHOTIC AGENTS; BINDING SITES; BINDING, COMPETITIVE; HIPPOCAMPUS; HUMANS; INTERNEURONS; NEURAL INHIBITION; PYRAMIDAL CELLS; RECEPTORS, GABA; SCHIZOPHRENIA; SYNAPSES;

EID: 0032778735     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00136-5     Document Type: Conference Paper

References (93)

1. Abercrombie M. Estimation of nuclear population from microtomic sections. Anat Rev. 94:1946;239.
2. Adler L.A., Pachtman E., Franks F.D., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 17:1982;639-654.
3. Akbarian S., Huntsman M.M., Kim J.J., Tafazzoli A., Potkin S.G., Bunney W.E., et al. GABAA receptor subunit gene expression in human prefrontal cortex comparison of schizophrenics and controls . Cereb Cortex. 5:1995;550-560.
4. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-278.
5. Amaral D.G., Kurz J. The time of origin of cells demonstrating glutamic acid decarboxylase-like immunoreactivity in the hippocampal formation of the rat. Neurosci Lett. 59:1985;33-39.
6. Angevine J.B. Time of neuron origin in the hippocampal region an autoradiographic study in the mouse . Exp Neurol. 13:1965;1-70.
7. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry. 152:1995;738-748.
8. Benes F.M. A neurodevelopmental approach to the understanding of schizophrenia and other mental disorders. Cicchetti D., Cohen D.J. Developmental Psychopathology, Vol. 1 Theory and Methods . 1995;227-253 John Wiley & Sons, Inc, New York.
9. Benes F.M. Post-mortem structural analyses of schizophrenic brain. Study designs and the interpretation of data. Psychiat Dev. 6:1988;213-226.
10. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of cerebral cortex of schizophrenics. Arch Gen Psychiat. 43:1986;31-35.
11. Benes F.M., Khan Y., Vincent S.L., Wickramasinghe R. Differences in the subregional and cellular distribution of GABA-A receptor binding in the hippocampal formation of schizophrenic brain. Synapse. 22:1996;338-349.
12. Benes F.M., Marie A., Vincent S., Khan Y. Upregulation of GABA-A receptor binding on PNsneurons of prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
13. Benes F.M., McSparren J., Bird E.D., Vincent S.L., SanGiovanni J.P. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients. Arch Gen Psychiat. 48:1991;996-1001.
14. Benes F.M., Sorensen I., Bird E.D. Morphometric analyses of the hippocampal formation in schizophrenic brain. Schizophr Bull. 17:1991;597-608.
15. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., SanGiovanni J.-P. Increased GABA receptor binding in supragranular layers of schizophrenic cingulate cortex. J Neurosci. 12:1992;924-929.
16. A and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res. 55:1997;121-129.
17. Bentoviglio M., Kultas-Ilinsky K., Ilinsky I. Limbic thalamus Structure, intrinsic organization, and connections . Vogt B.A., Gabriel M. Neurobiology of Cingulate Cortex and Limbic Thalamus. 1993;71-122 Birkhauser, Boston.
18. Boutros N.N., Zouridakis G., Overall J. Replication and extension of P50 findings in schizophrenia. Clin Electroencephalograph. 22:1991;40-45.
19. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:1992;206-215.
20. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick I.D., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 14:1978;339-343.
21. Cameron N. Reasoning, regression and communication in schizophrenics. Psychol Rev Monographs. 50:1938;1-33.
22. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cell and synapses A case for more uniform standards of review . J Comp Neurol. 364:1996;6-15.
23. Cohen N.J., Eichenbaum H. Memory, Amnesia, and the HIPP System. 1993;MIT Press, Cambridge.
24. Colon E.J. Quantitative cytoarchitectonics of the human cerebral cortex. Psychiat Neurol Neurochir. 74:1971;291-302.
25. Detre TP, Jarecki HG (1971): Schizophrenic disorders. Modern Psychiatric Treatment Philadelphia: J.B. Lippincott Company, pp 108-116.
26. Dom R (1976): Neostriatal and thalamic interneurons. Their role in the pathophysiology of Huntington's chorea, Parkinson's disease and catatonic schizophrenia. Doctoral dissertation. Leuven: Katholieke Universiteit Leuven.
27. Domesick V.B. Projections from the cingulate cortex in the rat. Brain Res. 12:1969;296-320.
28. Eichenbaum H. Declarative memory Insights from cognitive neurobiology . Ann Rev Psychol. 48:1997;547-572.
29. Falkai P., Bogerts B. Cell loss in the HIPP of schizophrenics. Eur Arch Psychiatry Neurol Sci. 236:1986;154-161.
30. Feldman S., Robinson S. Electrical activity of the brain in adrenalectomized rats with implanted electrodes. J Neurol Sci. 6:1968;1-8.
31. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia Comparison of medicated and drug-free patients . Biol Psychiatry. 18:1983;537-551.
32. Gilles F.H., Shankle W., Dooling E.C. Myelinated tracts Growth patterns . Gilles F.H., Leviton A., Dooling E.C. The Developing Human Brain. Growth and Epidemiologic Neuropathology. 1983;117-183 John Wright-PSG Inc, Boston.
33. Goldman-Rakic P.S., Selemon L.D., Schwartz M.L. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience. 12:1984;719-743.
34. Gundersen H.J.G., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., et al. The new stereological tools Director, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis . Acta Pathol Methodol Immunol Sci. 96:1988;857-881.
35. Heckers S., Heinsen H., Geiger B., Beckmann H. Hippocampal neuron number in schizophrenia. Arch Gen Psychiatry. 48:1991;1002-1008.
36. Heckers S., Rausch S.L., Goff D., Savage O.R., Schachter D.L., Fischman A.J., Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature Neurosci. 1:1998;318-323.
37. Ikonomidou C., Mosinger L.L., Shahid Sallett K., Labruyere J., Olney J.W. Sensitivity of the developing rat brain to hyperbaric/ischemic damage parallels sensitivity to N-methyl-D-aspartate neurotoxicity. J Neurosci. 9:1989;2809-2818.
38. Irle E., Markowitsch H.J. Widespread cortical projection of the hippocampal formation in the cat. Neuroscience. 7:1982;2637-2647.
39. Jakob H., Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neurol Trans. 65:1986;303-326.
40. Jeste D., Lohr J.B. Hippocampal pathologic findings in schizophrenia. Arch Gen Psychiatry. 46:1989;1019-1024.
41. Johnson E.W., de Lanerolle N.C., Kim J.H., Sundaresan S., Spencer D., Mattson D., et al. "Central" and "peripheral" benzodiazepine receptors Opposite changes in human epileptogenic tissue . Neurology. 42:1992;811-815.
42. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem. 56:1991;720-723.
43. Kerwin R.W., Patel S., Meldrum B.S. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience. 39:1990;25-32.
44. Kerwin R.W., Patel S., Meldrum B.S., Czudek C., Reynolds G.P. Asymmetrical loss of glutamate receptor subtype in left HIPP in schizophrenia. Lancet. 1:1988;583-584.
45. Kovelman J.A., Scheibel A.B. A neurohistological correlate of schizophrenia. Biol Psychiatry. 19:1984;1601-1621.
46. A receptor. Trends Pharmacol Sci. 8:1987;224-227.
47. A/benzodiazepine receptor α1, β2, and γ2 subunit mRNA expression in cerebellar Purkinje cells of staggerer mutant mice. J Neurosci. 15:1995;8121-8130.
48. Matussek P. Untersuchunger uber die wahnwahrenmung. I Mitteilung Verangerunger der Wahrenhmungswelt bei beginnenden, primaren Wahn . Arch Psychiat Nervenkl. 189:1951;279-319.
49. A receptors in brain. Brain Res. 339:1985;178-182.
50. McCarley R.W., Faux S.F., Shenton M.E., Cane M., LeMay M., Ballinger R., et al. CT abnormalities in schizophrenia A preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms . Arch Gen Psychiatry. 46:1989;698-708.
51. McCarley RW, Faux SF, Shenton ME, Nestor PG, Adams J (1991): Event-related potentials in schizophrenia: Their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophr Res 1991;4:209-31.
52. McEwen B.S. Glucocorticoids and HIPP Receptors in search of a function . Ganten D., Pfaff D. Adrenal Actions on Brain. 1982;1-22 Springer-Verlag, Berlin.
53. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Brit J Med Psychol. 34:1961;103-116.
54. Miller A.L., Chaptal C., McEwen B.S., Beck J.R.E. Modulation of high affinity GABA uptake into hippocampal synaptosomes by glucocorticoids. Psychoneuroendocrinology. 3:1978;155-164.
55. Monaghan D.T., Cotman C.W. Distribution of N-methyl-D-aspartate-sensitive L-3H-glutamate-binding sites in rat brain. J Neurosci. 5:1985;2905-2919.
56. Olney J.W., Sesma M.A., Wozniak D.F. Glutamatergic, cholinergic and GABAergic systems in posterior cingulate cortex Interactions and possible mechanisms of limbic system disease . Vogt B.A., Gabriel M. Neurobiology of Cingulate Cortex and Limbic Thalamus. 1993;557-580 Birkhäuser Publishing, Boston.
57. Pandya D.N., Van Hoesen G.W., Mesulam M.-M. Efferent connections of the cingulate gyrus in the Rhesus monkey. Exp Brain Res. 42:1981;319-330.
58. Payne R.W., Matussek P., George E.I. Experimental study of schizophrenic thought disorder. Brit J Psychiat. 108:1961;362-367.
59. Pfaff D.W., Silva M.T.A., Weiss J.M. Telemetered recording of hormone effects on hippocampal neurons. Science. 172:1971;394-395.
60. A receptor research . Synapse. 21:1995;189-274.
61. Rakic P. Developmental events leading to laminar and area organization of the neocortex. Schmitt F.O. The Organization of Cerebral Cortex. 1981;7-27 MIT Press, Cambridge.
62. Rakic P., Nowakowski R. The time of origin of neurons in the hippocampal region of the rhesus monkey. J Comp Neurol. 196:1981;99-128.
63. Ramon Y Cajal S (1911): Histologi du system nerveux del nomme et du vertebrates. In: Ramon Y Cajal S, Eds. Consejo Superior de Investigaciones Cintificos Instituto. Madrid, Spain. II.
64. Represa A., Tremblay E., Ben-Ari Y. Transient increase of NMDA-binding sites in human HIPP during development. Neurosci Lett. 99:1989;61-66.
65. Rosene DL, Van Hoesen GW (1987): The hippocampal formation of the primate brain. In: Peters A, Jones EG, editors, Cerebral Cortex. New York: Plenum Press; 1987. 6: Further Aspects of Cortical Function, Including Hippocampus. pp 345-456.
66. Rothman S.M., Olney J.W. Glutamate and the pathology of ischemic/hypoxic brain damage. Ann Neurol. 19:1986;105-115.
67. Rozenberg F., Robain O., Jardin L., Ben-Ari Y. Distribution of GABAergic neurons in late fetal and early postnatal rat HIPP. Dev Brain Res. 50:1989;177-187.
68. Saccuzzo D.P., Braff D.L. Information-processing abnormalities Trait-and state-dependent component . Schizpr Bull. 2:1986;447-456.
69. Saper C.B. Any way you cut it A new journal policy for the use of unbiased counting methods . J Comp Neurol. 364:1996;5.
70. Sapolsky R.M. Stress, the Aging Brain, and the Mechanisms of Neuron Death. 1992;MIT Press, Cambridge.
71. Schlessinger A.R., Cowan W.M., Swanson L.W. The time of origin of neurons in Ammon's horn and the associated retrohippocampal fields. Anat Embryol. 154:1978;153-173.
72. Schwarcz R., Coyle J.T. Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat. Life Sci. 20:1997;431-436.
73. Schwob J.E., Fuller T., Price J.L., Olney J.W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid A histological study . Neuroscience. 5:1980;991-1014.
74. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex A morphometric analysis of prefrontal area 9 and occipital area 17 . Arch Gen Psychiat. 52:1995;805-818.
75. Seress L., Ribak C.E. The development of GABAergic neurons in the rat hippocampal formation. An immunocytochemical study. Dev Brain Res. 44:1988;197-202.
76. Sidman R., Rakic P. Neuronal migration with special reference to developing human brain. Brain Res. 62:1973;1-35.
77. Siegel R.E. The mRNAs encoding GABAA/benzodiazepine receptor subunits are localized in different cell populations of the bovine cerebellum. Neuron. 1:1988;579-584.
78. Somogyi P., Cowey A. Double bouquet cells. Peter A., Jones E.G. Cerebral Cortex. 1. Cellular Components of Cerebral Cortex. 1984;337-360 Plenum Press, New York.
79. Soriano E., Cobas S.A., Fairen A. Asynchronism in the neurogenesis of GABAergic and non-GABAergic neurons in the mouse HIPP. Dev Brain Res. 30:1986;88-92.
80. 3H]-Flunitrazepam bindings in cingulate cortex and hippocampus of postmortem schizophrenic brains. Neurochem Res. 18:1993;219-223.
81. Stanfield B.B., Cowan W.M. The development of hippocampal region. Peters A., Jones E.G. Cerebral Cortex. Development and Maturation of Cerebral Cortex. 1988;91-132 Plenum Press, New York.
82. Steiner H.X., McBean G.J., Kohler C., Roberts P.J., Schwarcz R. Ibotenate-induced neuronal degeneration in immature rat brain. Brain Res. 307:1984;117-124.
83. Stumpf W.E., Heiss C., Sar M., Duncan G.E., Craver C. Dexamethasone and corticosterone receptor sites. Histochemistry. 92:1989;201-210.
84. Swann J.W., Brady R.J., Martin D.L. Postnatal development of GABA-mediated synaptic inhibition in rate HIPP. Neuroscience. 28:1989;551-561.
85. 65 immunoreactive puncta on PNsand nonPNsneurons in HIPP of schizophrenic brain. Synapse. 29:1998;323-332.
86. Vogt B.A., Miller M. Cortical connections between rat cingulate cortex and visual, motor and post-subicular cortices. J Comp Neurol. 216:1983;192-210.
87. Vogt B.A., Sikes R.W., Vogt L.J. Anterior cingulate cortex and the medial pain system. Vogt B.A., Gabriel M. Neurobiology of Cingulate Cortex and Limbic Thalamus. 1993;313-344 Birkhäuser, Boston.
88. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:1987;660-669.
89. Williams R.W., Rakic P. Three-dimensional counting An accurate and direct method to estimate numbers of cells in sectioned material . J Comp Neurol. 278:1988;344-352.
90. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci. 12:1992;1040-1062.
91. Woodbury D.M. Effects of adrenocortical steroids Separability of anticonvulsant from hormonal effects . J Pharmacol Exp Ther. 153:1952;337-343.
92. 3H]glutamate binding in primate brain. J Neurosci Res. 27:1990;512-521.
93. Zhang W.Q., Rogers B.C., Tandon P., Hudson P.M., Sobotka T.J., Hong J.S., et al. Systemic administration of kainic acid increases GABA levels in perfusate from the HIPP of rats in vivo. Neurotoxicology. 11:1990;593-600.